Formulation and Evaluation of Gastroretentive Nanoparticles of Repaglinide

DOI:

https://doi.org/10.37285/ijpsn.2014.7.1.8

Authors

  • P M Jamkar
  • K N Gujar
  • S B Nemmaniwar
  • N B Kulkarni

Abstract

Controlled drug release system is one of the most favourable technique of novel drug delivery system owing to its reproducibility and ease of formulation. Nanotechnology is very useful for controlling the drug release and thus improving the pharmacokinetic and pharmacodynamic properties of the drug. The technique improves patient compliance by reducing both dose and the frequency of administration and thus minimizing the local as well as systemic toxic effects. The aim of the present research work was to formulate and evaluate gastroretentive nanoparticles of Repaglinide, an anti-diabetic drug by using the ionotropic gelation method. Repaglinide has a very short half-life of 1 hour with bioavailability 56%. Sustained release mucoadhesive nanoparticles of Repaglinide were prepared to increase the drug residence time in gastrointestinal tract and thus improving the bioavailability of drug. The mucoadhesive nanoparticles were prepared by using chitosan and sodium alginate as polymers; calcium chloride as the crosslinking agent. Different formulations were prepared with varying concentrations of chitosan and sodium alginate in order to achieve the optimum particle size and maximum encapsulation efficiency. The particle size of nanoparticles was found to be in the range of 300 nm to 756 nm. Drug encapsulation efficiency ranged between 56% to 80% with controlled drug release upto 88% in phosphate buffer pH 7.4 and 75% drug release in 0.1N HCl in 12 hrs. FT-IR and DSC studies showed that the drug and polymers were compatible. The results of swelling study and bioadhesive strength indicated that optimized formulation exhibited excellent mucoadhesive properties

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Nanoparticles, Chitosan, sodium alginate, calcium chloride, ionotropic gelation, mucoadhesive

Downloads

Published

2014-02-28

How to Cite

1.
Jamkar PM, Gujar KN, Nemmaniwar SB, Kulkarni NB. Formulation and Evaluation of Gastroretentive Nanoparticles of Repaglinide. Scopus Indexed [Internet]. 2014 Feb. 28 [cited 2024 Dec. 10];7(1):2363-70. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/701

Issue

Section

Research Articles

References

Arora G, Malik K, Singh I and Arora S (2011). Formulation and evaluation of controlled release mucoadhesive matrix tablets: assessment of myrrh oleo gum resin as a natural pharmaceutical excipient. International Journal of Pharmaceutical Sciences and Drug Research 3(2): 84-88.

Bagul U, Gujar K, Dhat S, Aphale S and Miken B (2009). In vitro study of mucoadhesive strength of polymers for mucoadhesive drug delivery systems. International Journal of Current Pharmaceutical Research 1(1): 42-44.

Behera A and Sahoo SK (2012). Development and in vitro, in vivo evaluation of controlled release, biocompatible nanoparticles. Digest Journal of Nanomaterials and Biostructures 7(1): 217-225.

Bhanja S, Ellaiah P, Martha SK, Singh P, Panigrahi BB and Das D (2010). Design and in-vitro evaluation of mucoadhesive buccal tablets of repaglinide. Int J Pharma Sci Tech 4(1): 42-53.

DhanaLekshmi UM, Poovi G, and Neelakanta Reddy P (2012). In-vitro observation of repaglinide engineered polymeric nanoparticles. Digest Journal of Nanomaterials and Biostructures 7(1): 1 –20.

Gupta VK and Karar PK (2012). Preparation and optimization of process variables of nanoparticles containing anti-cancer drug. International Journal of Pharma and Bio Sciences 3(2): 166-173.

Khurana S and Sateesh NV (2011). Mucoadhesive drug delivery: mechanism and methods of Evaluation. International Journal of Pharma and Bio Sciences 2(1): 458-467.

Krishna Sailaja A, Amareshwar P and Chakravarty P (2010). Chitosan nanoparticles as a drug delivery system. Research Journal of Pharmaceutical, Biological and Chemical Sciences 1(3): 474-484.

Maruthi G, Anton Smith A and Manavalan R (2011). Nanoparticles – A Review. Journal of Advanced Scientific Research 2(4): 12-19.

Mohanraj VJ and Chen Y (2006). Nanoparticles – a review. Tropical Journal of Pharmaceutical Research 5(1): 561-573.

Mulla JAS, Hiremath SP and Sharma NK (2012). Repaglinide loaded solid lipid nanoparticles: design and characterization. Research journal of pharmaceutical sciences 1(2): 41-49.

Naik JB and Mokale VJ (2012). Formulation and evaluation of repaglinide nanoparticles as a sustained release carrier. Novel Science International Journal of Pharmaceutical Science 1(5): 259-266.

Patel JK and Jivani NP (2009). Chitosan based nanoparticles in drug delivery. International Journal of Pharmaceutical Sciences and Nanotechnology 2(2): 517-522.

Ping Li, Ya-Ni Dai, Jun-Ping Zhang, Ai-Qin Wang and Qin Wei (2008). Chitosan–alginate nanoparticles as a novel drug delivery system for nifedipine. International Journal of Biomedical Science 4(3): 221-228

Pristy AK and Sahu SK (2009). Biodegradable nanoparticles- a novel approach for oral administration of biological products. International Journal of Pharmaceutical Sciences and Nanotechnology 2(2): 503-508.

Shaikh A, pawar YD and Kumbhar ST (2012). An in-vitro study for mucoadhesion and control release properties of guar gum and chitosan in itraconazole mucoadhesive tablets. International Journal of Pharmaceutical Sciences and Research 3(5): 1411-1414.

Shinde GV, Sudharshini S, Stephenrathinaraj B, Rajveer CH, Kumaraswamy D and Bangale GS (2010). Formulation and evaluation of mucoadhesive tablets of niacin using different bioadhesive polymers. International Journal of Pharma and Bio Science 1(2): 1-14.

Varma MM and Rao ChHLN (2013). Evaluation of aceclofenac loaded alginate mucoadhesive spheres prepared by ionic gelation. International Journal of Pharmaceutical Sciences and nanotechnology 5(4): 1847-1857.

Vijayan V, Jayachandran E, Anburaj J, Srinivasa Rao D and Jayaraj Kumar K (2011). Transdermal delivery of repaglinide from solid lipid nanoparticles in diabetic rats: in vitro and in vivo studies. Journal of Pharmaceutical Sciences Research 3(3): 1077-1081.